Learnings from past failures: Future routes of antimicrobial drug discovery
Drug Discov Today, 2021 Jul 24; S1359-6446(21)00323-8. doi: 10.1016/j.drudis.2021.07.017
Maximization of non-nitrogenous metabolite production in E. coli using population systems biology.
Sreenath Rajagopal, Arindam Ghatak, Debdatto Mukherjee, Rothangmawi Victoria Hmar, Anirudh P. Shanbhag, Nainesh Katagihallimath, Janani Venkataraman, KS Ramanujan, Santanu Datta
– bioRxiv, Dec 2019
Functional characterization of the efflux pump OqxAB by complementation assays in E. coli. Gordon Research Conference 2019
Purnendu Bhowmik, Anirudh P Shanbhag, Nagakumar Bharatham and Nainesh Katagihallimath.
Multi-Drug Efflux Systems. Lucca, Italy.
In Vitro Activity of BWC0977 (a Novel Bacterial Topoisomerase Inhibitor) and Comparators against Recent Clinical and Molecularly Characterized Enterobacteriaceae and Non-Fermenter Isolates from the United States and Europe
Michael D. Huband, Jill M. Lindley, Amy A. Watters, Holly K. Becker, Vasanthi Ramachandran, V. Balasubramanian, Robert K. Flamm.
ECCMID 2019, Amsterdam. Poster #P1847.
In vitro Activity of BWC0977, a Novel Bacterial Topoisomerase Inhibitor, against Molecularly Characterized Enterobacteriaceae & Non-Fermenter Isolates of the CDC collection and key Biodefense Pathogens
Nathan P. Wiederhold, Maria McElmeel, Thomas F. Patterson, Richard A.
Slayden, Jason E. Cummings, Vasanthi Ramachandran, Shahul Hameed and V. Balasubramanian
ECCMID 2019, Amsterdam. Poster #P1845.
In Vitro Activity of BWC0977 (a Novel Bacterial Topoisomerase Inhibitor) and Comparators against Recent Clinical Enterobacteriaceae and Non-Fermenter Isolates from two hospitals in Bengaluru, India